Archives

img-01

Conducting Clinical Trials in Asia

With steadily increasing drug development costs and significant time spent on clinical trials, outsourcing clinical trials in Asia has rapidly become an appealing option for many firms. As developing a single drug can cost more than $200 million and take at least... Read More

img-01

Approval for the Central Drugs Authority of India

The Government of India’s Union Cabinet has approved the establishment of the Central Drugs Authority of India. This Authority would be an autonomous organization under the Ministry of Health & Family Welfare. Currently, the Central Drug Standards Control Organization works with the... Read More

img-01

New Regulations for Global Clinical Trials in India

India’s Central Drugs Standard Control Organization (CDSCO) has recently passed new regulations on global clinical trials. The regulations are based on a meeting held in October 2006, which brought together clinical trial specialists, manufacturers’ associations, and contract research organizations. In the process... Read More

img-01

India’s Increasing Clinical Trial Trend

With soaring clinical trial costs and long development periods, many companies have turned to India to conduct cheaper, faster clinical trials. The potential cost savings of 40 to 60 percent together with a large, ethnically diverse population and an increasing pool of... Read More

img-01

Asia Orthopedics Update

Asia has a population of over 4 billion people, and represents about 60% of the world's population. Annual economic growth rates in the Asian countries have been as high as 8 or 10% over the past decade, in comparison with some developed... Read More